首页> 外文期刊>Clinical ophthalmology >Utility values for glaucoma in Brazil and their correlation with visual function
【24h】

Utility values for glaucoma in Brazil and their correlation with visual function

机译:巴西青光眼的效用值及其与视觉功能的相关性

获取原文
           

摘要

Purpose: We sought to identify the utility values in a group of Brazilian patients with primary open-angle glaucoma (POAG), and to assess its impact on visual acuity (VA) and mean deviation index values. Materials and methods: This was a cross-sectional study of consecutive patients with POAG, who were interviewed using three methods for obtaining utility values: time trade-off (TTO), standard gamble anchored at risk of death (SG1), and standard gamble anchored at risk of blindness (SG2). Visual function variables (VA and mean deviation index in the better eye) and sociodemographic characteristics (age, sex, race, and educational level) were also obtained for statistical analysis. Results: The mean age (± standard deviation) of the study population (n=227) was 65.7 (±15.1) years. Mean utility values for the entire population were 0.82 from TTO, 0.90 from SG1, and 0.93 from SG2 (P<0.0001). Age, race, and sex had no influence on the utility values. Higher education tended to predict higher values by TTO, but not by SG1 or SG2. Visual function variables had an influence on utility values. The more advanced the visual loss, whether measured by VA or perimetry, in the better eye, the lower the utility values by all three methods. Conclusion: We obtained utility values for Brazilian patients with POAG, as well as specific values for different levels of vision loss.
机译:目的:我们试图确定一组巴西原发性开角型青光眼(POAG)患者的效用值,并评估其对视敏度(VA)和平均偏差指数值的影响。材料和方法:这是对连续性POAG患者的横断面研究,他们接受了三种获取效用价值的方法的访谈:时间权衡(TTO),锚定有死亡风险的标准赌博(SG1)和标准赌博处于失明危险中(SG2)。还获得了视觉功能变量(VA和更好的眼睛平均偏差指数)和社会人口统计学特征(年龄,性别,种族和教育程度)进行统计分析。结果:研究人群(n = 227)的平均年龄(±标准偏差)为65.7(±15.1)岁。整个人群的平均效用值为TTO的0.82,SG1的0.90,SG2的0.93(P <0.0001)。年龄,种族和性别对效用值没有影响。高等教育倾向于通过TTO来预测更高的价值,但不是通过SG1或SG2来预测。视觉功能变量对效用值有影响。无论是通过VA还是通过视野检查法测得的视力丧失越先进,越好眼睛,这三种方法的实用价值就越低。结论:我们获得了巴西POAG患者的效用值,以及不同水平视力丧失的具体值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号